G. M. Verleden (Leuven, Belgium), P. Corris (Newcastle upon Tyne, United Kingdom)
Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation
P. Jaksch, C. Aigner, C. Czebe, W. Wisser, W. Klepetko (Vienna, Austria)
|  |
Predictors of survival of patients waiting for lung transplantation
K. Stavem, O. Bjørtuft, O. R. Geiran, J. Boe (Nordbyhagen, Oslo, Norway)
| |
The outcomes of lung transplantation in patients with bronchiectasis and antibody deficiency
J. A. Nathan, L. D. Sharples, E. Andrew, P. Sivasothy, W. D. John (Cambridge, United Kingdom)
| |
Results of switch from mycophenolate mofetil to azathioprin after lung transplantation
H. Boettcher, H. B. Lehmkuhl, M. Bettmann, R. Hetzer (Berlin, Germany)
| |
Quantitative PCR for early detection of cytomegalovirus after lung transplantation
C. Eich, W. Bossart, R. Speich, E. Russi, A. Boehler (Zurich, Switzerland)
| |
Aspergillus infections in lung transplant recipients. Risk factors and outcome
A. Solé, P. Morales, P. Morant, M. Salavert, J. Pemán, V. Calvo (Valencia, Spain)
| |
The effect of bronchiolitis obliterans sydrome on health related quality of life
K. M. Vermeulen, H. Groen, W. van der Bij, G. H. Koeter, E. M. TenVergert (Groningen, The Netherlands)
| |
Stress, anxiety and coping in patients on the waiting list for a lung transplantation
K. M. Vermeulen, W. van der Bij, O. H. Bosma, G. H. Koeter, E. M. TenVergert (Groningen, The Netherlands)
| |
Changes in quality of life in COPD candidates for lung transplantation (one year observation)
A. Wojdyla, D. Jastrzebski, A. Krzywiecki, D. Ziora, J. Kozielski (Zabrze, Poland)
| |
Neutrophil mediated matrixmetalloproteinase activity is increased in bronchiolitis obliterans syndrome after lung transplantation
R. H. Hubner, S. Meffert, U. Mundt, S. Freitag, S. Hirt, N. E. El Mokhtari, U. R. Folsch, B. Bewig (Kiel, Germany)
| |
IL-17 upregulates IL-8 release by primary bronchial epithelial cells derived from stable lung allografts
D. M. Murphy, I. A. Forrest, C. Ward, G. Pritchard, D. Jones, T. E. Cawston, J. J. Egan, P. A. Corris, J. L. Lordan (Newcastle, United Kingdom; Dublin, Ireland)
| |
II-17 upregulation in BAL-fluid during acute rejection after lung transplantation: a 3 months follow-up
B. M. Vanaudenaerde, L. J. Dupont, W. A. Wuyts, S. Seghers, D. E. Van Raemdonck, G. M. Verleden (Leuven, Belgium)
| |
Epithelial mesenchymal transition in lung allografts
C. Ward, I. A. Forrest, H. Robertson, D. M. Murphy, G. Pritchard, J. L. Lordan, T. E. Cawston, J. A. Kirby, P. A. Corris (Newcastle-upon-Tyne, United Kingdom)
| |
TGF-β upregulates matrix metalloproteinase secretion by bronchial epithelial cells derived from lung allografts
I. Forrest, D. Murphy, C. Ward, D. Jones, H. Robertson, J. Kirby, J. Lordan, T. Cawston, P. A. Corris (Newcastle-upon-Tyne, United Kingdom)
| |
Lung donors shortage and use of marginal donors in Italy: the experience of the Torino lung transplant program
P. L. Filosso, A. Cavallo, E. Ruffini, S. Baldi, D. Libertucci, P. Solidoro (Torino, Jamaica; Torino, Italy)
| |
The use of impulse oscillometry (IOS) in double lung transplant recepients
C. Houghton, D. Allen, N. Clayton, A. Woodcock, C. Leonard, D. Singh (Manchester, United Kingdom)
| |
Effects of cold preservation on the whole lung and lung tissue mechanics in the rat
K. Ikeyama, H. Sakai, M. Omasa, H. Hamakawa, T. Fujinaga, T. Fukuse, H. Wada (Kyoto, Japan)
| |
Pulmonary complications in heart transplant recipients
F. Elmas Uysal, A. Atasever, S. Nalbantgil, T. Yagdi, A. Guzelant, F. Bacakoglu (Izmir, Turkey)
| |
Indication and selection patients before lung transplantation – our experience of 01/00-01/04
R. Davidova (Prague, Czech Republic)
| |
Role of HCRT with density mask technique in the follow-up of diffuse cystic lung diseases
G. Paciocco, R. Cassandro, E. Uslenghi, A. Bianchi, L. L. Longo, S. Harari (Milan, Italy)
| |